|
2016
|
Invention
|
Heteroaryl compounds and uses thereof.
The present invention provides compounds, pharmaceuticall... |
|
|
Invention
|
Heteroaryl compounds, synthesis thereof, and intermediates thereto. The present invention relates... |
|
2015
|
Invention
|
Heteroaryl compounds and uses thereof. The present invention provides compounds which inhibit one... |
|
|
Invention
|
Methods of treatment using an erk inhibitor. The present invention provides methods of treating, ... |
|
|
Invention
|
Combinations of an erk inhibitor and an egfr inhibitor and related methods. The present invention... |
|
|
Invention
|
Combinations of an erk inhibitor and a bcl-2 pathway modulator and related methods. The present i... |
|
|
Invention
|
Combinations of an erk inhibitor and a pi3k inhibitor or dual pi3k/tor inhibitor and related meth... |
|
|
Invention
|
Oral formulations and uses thereof. The present invention provides pharmaceutical formulations co... |
|
|
Invention
|
Combinations of an erk inhibitor and a chemotherapeutic agent and related methods. The present in... |
|
|
Invention
|
Heteroaryl compounds and uses thereof. The present invention provides compounds, pharmaceutically... |
|
|
Invention
|
Combinations of an erk inhibitor and a raf inhibitor and related methods. The present invention p... |
|
|
Invention
|
Combinations of an erk inhibitor and a dot1l inhibitor and related methods. The present invention... |
|
|
Invention
|
Combinations of an erk inhibitor and a cdk4/6 inhibitor and related methods. The present inventio... |
|
|
Invention
|
Combinations of an erk inhibitor and a tor inhibitor and related methods. The present invention p... |
|
|
Invention
|
Heterocyclic compounds and uses thereof.
The present invention provides compounds, pharmaceutica... |
|
|
Invention
|
4,6-disubstituted pyrimidines as kinase inhibitors. The present invention provides 4,6-disubstitu... |
|
|
Invention
|
Methods of treating a bruton's tyrosine kinase disease or disorder. The present invention provide... |
|
2014
|
Invention
|
Substituted pyrimidines as protein kinase inhibitors. The present invention provides 4,6-diaminop... |
|
|
Invention
|
Hcv protease inhibitors and uses thereof.
The present invention provides compounds, pharmaceutic... |
|
|
Invention
|
Heteroaryl compounds and uses thereof. The present invention relates to compounds useful as inhib... |
|
|
Invention
|
Erk inhibitors and uses thereof. Compounds, compositions thereof, and methods for inhibiting one ... |
|
|
Invention
|
Mk2 inhibitors and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
2013
|
Invention
|
Heteroaryl compounds and uses thereof. The present invention provides certain compounds, and comp... |
|
|
Invention
|
Methods of treating a disease or disorder associated with bruton's tyrosine kinase. The present i... |
|
|
Invention
|
Heterocyclic compounds and uses thereof. The present invention provides compounds, pharmaceutical... |
|
|
Invention
|
4,6-disubstituted pyrimidines useful as kinase inhibitors. The present invention provides 4,6-dis... |
|
|
Invention
|
Solid forms of an epidermal growth factor receptor kinase inhibitor. The present invention provid... |
|
|
Invention
|
Salts of an epidermal growth factor receptor kinase inhibitor. The present invention provides a s... |
|
2012
|
Invention
|
4,6-diaminopyrimidines useful as kinase inhibitors. The present invention provides 4,6-diaminopyr... |
|
|
Invention
|
Pi3 kinase inhibitors and uses thereof.
The present invention provides compounds, compositions t... |
|
|
Invention
|
Pi3 kinase inhibitors and uses thereof. The present invention provides compounds, compositions th... |
|
2011
|
Invention
|
Mutant-selective egfr inhibitors and uses thereof. The present invention provides compounds, phar... |
|
|
Invention
|
Heterocyclic compounds and uses thereof. Heterocyclic pyrimidine compounds that modulate mutant-s... |
|
|
Invention
|
Heteroaryl compounds and uses thereof. Heterocyclic pynmidine compounds that modulate mutant-sele... |
|
|
Invention
|
Besylate salt of a btk inhibitor. The present invention provides a salt form, and compositions th... |
|
|
Invention
|
4,6-disubstitued pyrimidines useful as kinase inhibitors. The present invention provides 4,6-disu... |
|
2009
|
Invention
|
Algorithm for designing irreversible inhibitors.
The invention is an algorithm and method for de... |
|
2008
|
Invention
|
4,6-disubstitued pyrimidines useful as kinase inhibitors. The present invention provides compound... |
|
|
Invention
|
Heterocyclic compounds and uses thereof.
The present invention provides compounds, pha... |
